PDS Biotechnology Corp (PDSB)
3.29
+0.06
(+1.70%)
USD |
NASDAQ |
Nov 05, 14:46
PDS Biotechnology Max Drawdown (5Y): 99.86% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
October 31, 2024 | 99.86% |
September 30, 2024 | 99.86% |
August 31, 2024 | 99.86% |
July 31, 2024 | 99.86% |
June 30, 2024 | 99.86% |
May 31, 2024 | 99.86% |
April 30, 2024 | 99.86% |
March 31, 2024 | 99.86% |
February 29, 2024 | 99.86% |
January 31, 2024 | 99.86% |
December 31, 2023 | 99.86% |
November 30, 2023 | 99.86% |
October 31, 2023 | 99.86% |
September 30, 2023 | 99.86% |
August 31, 2023 | 99.86% |
July 31, 2023 | 99.86% |
June 30, 2023 | 99.86% |
May 31, 2023 | 99.86% |
April 30, 2023 | 99.86% |
March 31, 2023 | 99.86% |
February 28, 2023 | 99.86% |
January 31, 2023 | 99.86% |
December 31, 2022 | 99.86% |
November 30, 2022 | 99.86% |
October 31, 2022 | 99.86% |
Date | Value |
---|---|
September 30, 2022 | 99.86% |
August 31, 2022 | 99.86% |
July 31, 2022 | 99.86% |
June 30, 2022 | 99.86% |
May 31, 2022 | 99.86% |
April 30, 2022 | 99.86% |
March 31, 2022 | 99.86% |
February 28, 2022 | 99.86% |
January 31, 2022 | 99.86% |
December 31, 2021 | 99.86% |
November 30, 2021 | 99.86% |
October 31, 2021 | 99.86% |
September 30, 2021 | 99.86% |
August 31, 2021 | 99.86% |
July 31, 2021 | 99.86% |
June 30, 2021 | 99.86% |
May 31, 2021 | 99.86% |
April 30, 2021 | 99.86% |
March 31, 2021 | 99.86% |
February 28, 2021 | 99.86% |
January 31, 2021 | 99.86% |
December 31, 2020 | 99.86% |
November 30, 2020 | 99.86% |
October 31, 2020 | 99.86% |
September 30, 2020 | 99.86% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
99.56%
Minimum
Nov 2019
99.86%
Maximum
Apr 2020
99.84%
Average
99.86%
Median
Apr 2020
Max Drawdown (5Y) Benchmarks
Chimerix Inc | 97.79% |
Cellectar Biosciences Inc | 99.69% |
Marinus Pharmaceuticals Inc | 98.49% |
Jaguar Health Inc | 100.00% |
Seres Therapeutics Inc | 98.52% |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | -26.19 |
Beta (5Y) | 1.931 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 124.9% |
Historical Sharpe Ratio (5Y) | -0.0101 |
Historical Sortino (5Y) | -0.0279 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 39.07% |